Skip to main content

Table 3 Result of simple regresssion analysis for detected oral streptococci

From: The significance of oral streptococci in patients with pneumonia with risk factors for aspiration: the bacterial floral analysis of 16S ribosomal RNA gene using bronchoalveolar lavage fluid

 

 b

SE (b)

 β

p-value

Age >80

13.92

4.47

0.229

0.002

BMI<20

−4.07

2.89

−0.106

0.161

Hospitalization for >2 days in the preceding 90 day; n (%)

4.15

4.63

0.068

0.371

Residence in a nursing home or long-term care facility

14.48

5.49

0.196

0.009

Home infusion therapy (including antibiotics)

9.88

7.26

0.102

0.170

ECOG PS of premorbid condition>3

23.37

4.87

0.341

<0.001

COPD

−0.28

5.60

−0.004

0.960

Interstitial pneumonia

0.18

7.92

0.002

0.982

Lung cancer

−0.16

9.55

−0.001

0.987

Bronchiectasis

−6.63

7.28

−0.069

0.364

Cerebrovascular disease

7.75

5.85

0.100

0.187

Neuromuscular diseases

8.62

7.09

0.092

0.226

Dementia

8.14

6.20

0.099

0.191

Gastroesophageal disorder

5.72

6.12

0.705

0.351

Pharyngeal disorder

19.48

11.22

0.130

0.084

Presence of the risk factor for aspiration

12.78

4.31

0.219

0.004

Malignancy excluding lung cancer

−1.73

5.10

−0.026

0.735

Psychiatric disease

1.68

12.18

0.010

0.891

Sleeping medications

10.24

6.08

0.126

0.094

Antipsychotic drugs

−4.94

10.61

−0.035

0.642

Antidepressant

10.40

10.01

0.078

0.300

History of pneumonia within the previous 1 year

16.12

4.92

0.241

0.001

Albumin<4 g/dl

−3.25

6.56

−0.037

0.621

Bilateral lung involvement

0.01

4.37

0.0002

0.998

Lower lobe opacity

−4.67

4.40

−0.08

0.291

Posterior dominant opacity

4.56

4.87

0.071

0.351

Gravity-dependent opacity

−7.52

5.27

−0.107

0.155

  1. Definition of abbreviations: BMI body mass index, ECOG PS eastern cooperative oncology group performance status, HCAP healthcare-associated pneumonia, COPD chronic obstructive pulmonary disease